Publications by authors named "Henk Codrington"

Claim this Profile
R
Real World Effectiveness of Durvalumab in Stage III Unresectable Non-small Cell Lung Cancer: What is the Role of PD-L1 Expression?
Hanieh Abedian Kalkhoran, Marjon V Verschueren, Bas J M Peters, Ewoudt M W van de Garde, Egbert F Smit, Henk Codrington

Clin Lung Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A text-mining approach to study the real-world effectiveness and potentially fatal immune-related adverse events of PD-1 and PD-L1 inhibitors in older patients with stage III/IV non-small cell lung cancer.
Hanieh Abedian Kalkhoran, Juliëtte Zwaveling, Bert N Storm, Sylvia A van Laar, Johanneke Ea Portielje, Henk Codrington

BMC Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life safety of PD-1 and PD-L1 inhibitors in older patients with cancer: An observational study.
Bert N Storm, Hanieh Abedian Kalkhoran, Erik B Wilms, Pepijn Brocken, Henk Codrington

J Geriatr Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of Geriatric 8 and Identification of Seniors at Risk for Hospitalized Patients Screening Tools for Patients With Lung Cancer.
Karlijn J G Schulkes, Esteban T D Souwer, Leontine J R van Elden, Henk Codrington, Simone van der Sar-van der Brugge

Clin Lung Cancer· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effect of A Geriatric Assessment on Treatment Decisions for Patients with Lung Cancer.
Karlijn J G Schulkes, Esteban T D Souwer, Marije E Hamaker, Henk Codrington, Simone van der Sar-van der Brugge

Lung· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of the Acidic Beverage Cola on the Absorption of Erlotinib in Patients With Non-Small-Cell Lung Cancer.
Roelof W F van Leeuwen, Robert Peric, Koen G A M Hussaarts, Emma Kienhuis, Nikki S IJzerman, Henk Codrington

J Clin Oncol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab.
Iris Walraven, Michel van den Heuvel, Judi van Diessen, Eva Schaake, Wilma Uyterlinde, Henk Codrington

Radiother Oncol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(
(18)F-fluorodeoxyglucose positron emission tomography versus computed tomography in predicting histopathological response to epidermal growth factor receptor-tyrosine kinase inhibitor treatment in resectable non-small cell lung cancer.
Matthijs H van Gool, Tjeerd S Aukema, Eva E Schaake, Herman Rijna, Henk E Codrington

Ann Surg Oncol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Additional weekly Cetuximab to concurrent chemoradiotherapy in locally advanced non-small cell lung carcinoma: efficacy and safety outcomes of a randomized, multi-center phase II study investigating.
Michel M van den Heuvel, Wilma Uyterlinde, Andrew D Vincent, Jeroen de Jong, Joachim Aerts, Henk Codrington

Radiother Oncol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor response and toxicity of neoadjuvant erlotinib in patients with early-stage non-small-cell lung cancer.
Eva E Schaake, Ingrid Kappers, Henk E Codrington, Renato A Valdés Olmos, Hendrik J Teertstra

J Clin Oncol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is 18F-FDG PET/CT useful for the early prediction of histopathologic response to neoadjuvant erlotinib in patients with non-small cell lung cancer?
Tjeerd S Aukema, Ingrid Kappers, Renato A Valdés Olmos, Henk E Codrington, Harm van Tinteren

J Nucl Med· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unusual pulmonary lesions: case 2. Endobronchial carcinoid of the lung.
Henk Codrington, Tom Sutedja, Richard Golding, Johan van Mourik, Elle Risse

J Clin Oncol· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis